• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Goodrx Holdings Inc Cl A (NQ: GDRX )

    7.800 +0.110 (+1.43%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,302,551
    Open 7.650
    Bid (Size) 7.600 (1)
    Ask (Size) 7.800 (1)
    Prev. Close 7.690
    Today's Range 7.540 - 7.810
    52wk Range 4.135 - 9.370
    Shares Outstanding 412,429,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Market Correction Alert: Sell These 3 Tech Stocks While You Can
    These tech stocks to sell combine shaky operational outlooks with underlying fundamental shakiness that don't bode well for the long-term. 
    Via InvestorPlace
    GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S.
    From GoodRx
    Via Business Wire

    Performance

    YTD
    +38.79%
    +38.79%
    1 Month
    +3.17%
    +3.17%
    3 Month
    +9.86%
    +9.86%
    6 Month
    +38.79%
    +38.79%
    1 Year
    +41.30%
    +41.30%

    More News

    Read More
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    The Analyst Landscape: 7 Takes On GoodRx Holdings
    Via Benzinga
    GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    GoodRx Holdings, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - GDRX
    From DJS Law Group
    Via Business Wire
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against GoodRx Holdings, Inc. (GDRX)
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    GDRX Investors Have Opportunity to Lead GoodRx Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Equinix and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    GDRX Investors Have Opportunity to Join GoodRx Holdings, Inc. Securities Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    3 Stocks to Sell ASAP Before the June 27 Presidential Debate
    Via InvestorPlace
    Rosen Law Firm Urges GoodRx Holdings, Inc. (GDRX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of GoodRx
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GoodRx, Exscientia, Malibu Boats, and Globe Life and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    GDRX INVESTOR ALERT: Kirby McInerney LLP Notifies GoodRx Holdings, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
    From Kirby McInerney LLP
    Via Business Wire
    INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in GoodRx Holdings, Inc. with Losses to Contact the Firm
    From Schall Law
    Via GlobeNewswire
    ROSEN, A LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important June 21 Deadline in Securities Class Action - GDRX
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, A LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important June 21 Deadline in Securities Class Action - GDRX
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    GOODRX HOLDINGS, INC. (NASDAQ: GDRX) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against GoodRx Holdings, Inc.
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX
    Via TheNewswire.com
    Topics Lawsuit
    Exposures Financial Legal
    GoodRx Holdings, Inc. NASDAQ: GDRX: Investors: June 21, 2024 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
    From Kessler Topaz Meltzer & Check, LLP
    Via Business Wire
    ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GDRX
    Via NewMediaWire
    Topics Lawsuit
    Exposures Financial Legal
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.